ARTICLE | Clinical News
PEG-formulation: Filed IND
October 4, 1993 7:00 AM UTC
Enzon Inc. (ENZN) Product: PEG-formulation of recombinant glucocerebrosidase, intramuscular injection Indication: Gaucher's disease Status: Filed IND to begin initial clinical trial. Note:ENZN hopes ...